| 書目名稱 | Phase II Clinical Development of New Drugs |
| 編輯 | Naitee Ting,Ding-Geng Chen,Joseph C. Cappelleri |
| 視頻video | http://file.papertrans.cn/746/745767/745767.mp4 |
| 概述 | First comprehensive book on the design and analysis of Phase II clinical trials.Provides step-by-step illustrations for data analysis using statistical software R and SAS.Serves as a reference book fo |
| 叢書名稱 | ICSA Book Series in Statistics |
| 圖書封面 |  |
| 描述 | This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them. |
| 出版日期 | Book 2017 |
| 關(guān)鍵詞 | Costs of Developing New Medicinal Products; Investment in Developing a New Drug; Phase III Clinical Tr |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-981-10-4194-5 |
| isbn_softcover | 978-981-13-5074-0 |
| isbn_ebook | 978-981-10-4194-5Series ISSN 2199-0980 Series E-ISSN 2199-0999 |
| issn_series | 2199-0980 |
| copyright | Springer Nature Singapore Pte Ltd. 2017 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-17 04:21
發(fā)表于 2025-3-21 17:35:58
